Immunotherapy

September 26, 2022

Now Enrolling: The EA2205 research study is testing a new treatment approach for a rare form of liver cancer

Researchers at ECOG-ACRIN are studying if they can improve results for patients with liver cancer by giving chemotherapy along with drugs that help the body’s immune system fight cancer
December 15, 2021

Trial Results: The DREAMseq trial provides strong evidence for a new treatment sequence for patients with BRAF-mutated advanced melanoma skin cancer

Dr. Michael Atkins, a medical oncologist who specializes in melanoma, talks about the results of the DREAMseq trial and how the information will hopefully extend life for more patients with advanced melanoma
March 3, 2021

Now Enrolling: Clinical trial EA2174 is evaluating a new treatment approach for patients with esophagus cancer

This trial is testing if the addition of immunotherapy to the usual treatment will lead to better results for patients with esophagus or gastroesophagus cancer
June 6, 2020

Ongoing Trial: EA3161 is testing maintenance immunotherapy versus observation in patients with HPV-related throat cancer

This trial is comparing chemotherapy and radiation to chemotherapy and radiation plus an immunotherapy drug.